PT Industri Jamu Sido Muncul stock (ID1000126402): MSCI index change hits Indonesian herbal producer

PT Industri Jamu Sido Muncul shares on the Indonesia Stock Exchange trade against a backdrop of MSCI index adjustments that removed the stock from a global small-cap index in May 2026, adding to pressure on Indonesian equities.

PT Industri Jamu Sido Muncul, listed on the Indonesia Stock Exchange (IDX) under the ticker SIDO, is trading in a market environment shaped by recent MSCI index changes that affected several Indonesian constituents in May 2026, including the herbal and pharmaceutical producer itself, according to a note from Taiwan's trade authority dated 05/13/2026 that summarized the MSCI Global Standard and Global Small Cap index reviews for Indonesia.

The Taiwan trade report, summarizing MSCI's May 2026 quarterly index adjustment, stated that MSCI's Global Standard Index changes on 05/12/2026 triggered broad selling pressure in Indonesia, with the Jakarta Composite Index falling 1.98% at the close on 05/13/2026 and posting a decline of more than 20% year-to-date at that time, underscoring how index-related flows and foreign investor positioning can influence stocks like PT Industri Jamu Sido Muncul that sit within the broader Indonesian equity universe.

Within the same document, PT Industri Jamu dan Farmasi Sido Muncul Tbk was listed among 13 Indonesian stocks removed from the MSCI Global Small Cap Index in the May 2026 review, alongside names from sectors such as mining, agriculture, banking, real estate and digital entertainment, highlighting that global index providers are rebalancing exposure to Indonesian mid- and small-cap stocks following the country's broader equity market pullback in 2026.

For local investors on IDX in Indonesia, the index removal means that certain passive and benchmark-driven global investors may reduce or reallocate positions in SIDO over time as MSCI-tracked portfolios adjust, even as domestic trading remains driven by company fundamentals, dividend expectations and sector dynamics in the traditional medicine and consumer health market.

In parallel, Indonesian media coverage on 06/01/2026 discussing the Jakarta Composite Index outlook around the 5,500-point level referenced SIDO among actively traded names when describing foreign flow and broader market sentiment, underscoring that PT Industri Jamu Sido Muncul remains part of the regular conversation about Indonesian equities despite its removal from one MSCI small-cap index.

For investors in Europe, SIDO can typically also be accessed via over-the-counter instruments or German trading venues such as Tradegate when available, although liquidity and spreads outside the home market tend to be lower than on IDX, which remains the primary marketplace for PT Industri Jamu Sido Muncul in Indonesian rupiah.

The company maintains an English-language investor relations page that provides access to financial statements, corporate presentations and shareholder information, supporting transparency for both domestic and international investors who follow PT Industri Jamu Sido Muncul as part of their exposure to Indonesia's consumer and healthcare sectors.

As of: 01/06/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Sido Muncul
• Sector/industry: Herbal medicine and consumer health products
• Headquarters/country: Semarang, Indonesia
• Core markets: Indonesia with exports to selected international markets
• Key revenue drivers: Sales of jamu-based herbal products, over-the-counter health drinks and related consumer goods
• Home exchange/listing venue: Indonesia Stock Exchange (SIDO)
• Trading currency: IDR

PT Industri Jamu Sido Muncul: core business model

PT Industri Jamu Sido Muncul focuses on producing and marketing traditional Indonesian jamu herbal remedies and related consumer health products, generating most of its revenue from branded packaged goods that target everyday wellness and over-the-counter health needs in Indonesia and selected export markets.

What banks and research houses say about PT Industri Jamu Sido Muncul

No verified analyst coverage was identified at the time of publication.

Conclusion

The recent MSCI index review in May 2026, which removed PT Industri Jamu Sido Muncul from a global small-cap benchmark, has added another layer of complexity to trading in SIDO alongside broader weakness in Indonesian equities. While no up-to-date named-bank research was verifiable at the time of writing, the company remains an established player in Indonesia's herbal and consumer health market, and its stock continues to be cited in local discussions about foreign flows and the trajectory of the Jakarta Composite Index.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.